Navigation Links
AIDS Vaccine Advocacy Coalition Voices Disappointment in Trial Result
Date:9/21/2007

Applauds Merck's Leadership and Calls for Reinvigorated Effort to Design

and Test AIDS Vaccines

NEW YORK, Sept. 21 /PRNewswire-USNewswire/ -- The AIDS Vaccine Advocacy Coalition (AVAC) released the following statement from Executive Director Mitchell Warren about the announcement that vaccinations have been discontinued in the STEP Study, a test-of-concept trial of the MRK-Ad5 AIDS vaccine candidate developed by the Merck Research Laboratories:

"Today's announcement about the STEP Study is a deep disappointment and a scientific setback for the AIDS vaccine field. However, it must be seen for what it is: the failure of a product to show efficacy in a specific trial. Clinical testing of AIDS vaccines is a scientific process and, while this is a disappointment, it is in no way the end of the search for an AIDS vaccine.

"These data are certainly not the ones that we had hoped for. The entire HIV vaccine field, including AVAC, had been looking to STEP and its companion Phambili trial in South Africa, to provide initial evidence of vaccine-related benefits. Even as the data disappoint, we also note the success of the STEP Study trial design in providing a swift answer to the critical question of whether or not the vaccine provided any benefits. A successful clinical trial is one that produces a scientifically accurate result. It may not be the result you had hoped for, but it answers questions that help the field move forward.

"We applaud Merck's tremendous leadership on HIV vaccine research. The company has set an example for the field, taking on one of the most important health technology challenges of our time. Merck and its collaborator, the US NIH-funded HIV Vaccine Trials Network, have been committed, strategic and willing to take risks at every stage of evaluating MRK-Ad5, and they must be commended for this. AVAC also recognizes the contributions of the thousands of volunteers in these trials. Their altrui
'/>"/>

SOURCE AIDS Vaccine Advocacy Coalition
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
3. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
4. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
5. Vaccine Can Prevent Cervical Cancer and Precancerous Lesions
6. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
7. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
8. HepaLifes PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference
9. New Flu Vaccine from PepTcell Could Provide Immunity Against All Strains of Influenza Virus
10. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
11. New Flu Vaccine From PepTcell Could Provide Immunity Against All Strains of Influenza Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... South Carolina , May 29, 2015 ... have announced a collaboration designed to provide therapeutic clinical ... majority of cancer patients living in U.S. communities. ... Health to harness the power of big data and ... thousands of patients to enable ,accrual on demand, for ...
(Date:5/29/2015)...  Haemonetics Corporation (NYSE: HAE ) announced today ... present at the JMP Securities Life Sciences Conference in ... rd , 2015 at 11:30am Eastern time.  ... via webcast at: http://wsw.com/webcast/jmp27/hae ... a global healthcare company dedicated to providing innovative blood ...
(Date:5/29/2015)... YORK , May 29, 2015  World-renowned prostate surgeon ... new findings on the benefit of MR/Ultrasound Fusion-Guided Biopsy ... "Our Prostate Cancer Center at Lenox Hill ... Fusion Biopsy System in New York City ... and low risk prostate cancers. The use of an MRI ...
Breaking Medicine Technology:New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 3New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 4MR/Ultrasound Fusion-Guided Biopsy Better Able to Detect Aggressive Prostate Cancer, New Study Says 2
(Date:5/29/2015)... San Diego, California (PRWEB) May 29, 2015 ... Common Core” and have joined the national effort to teach ... Many parents in the U.S. have been “sickened” by the ... country. However, love it or hate it, Common Core is ... the District of Columbia. Parents are now seeking ways ...
(Date:5/29/2015)... May 29, 2015 Intermountain ... partnered with Stratus Video Interpreting ... facilitate better communication and timely care for ... hearing loss. Stratus’ video remote interpreting (VRI) ... enabling staff to quickly access qualified medical ...
(Date:5/29/2015)... York, NY (PRWEB) May 29, 2015 ... USA Today, with a circulation of approximately 250,000 and ... distributed nationally, through a vast social media strategy, and ... outlets. To explore the digital version of the campaign, ... cover of the print publication. Inside, the actress, model ...
(Date:5/29/2015)... York, NY (PRWEB) May 29, 2015 ... on the “beauty of protection”. Skin Health is ... USA Today within the markets of New York, Los ... an estimated 750,000 readers. Its digital counterpart will reach ... content hubs. To read more the Skin Health campaign ...
(Date:5/29/2015)... OncLive proudly announces the 2015 ... recognized by a panel of eminent oncologists for landmark ... Honorees will be introduced and celebrated TONIGHT at the ... 8:30-11:00 p.m. CDT at The Chicago Illuminating Company, 2110 ... recognized for groundbreaking accomplishments, in fields including translational research, ...
Breaking Medicine News(10 mins):Health News:Doctors Discover a Cure for the Common Core 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 3Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 4Health News:Mediaplanet Launches “Skin Health” Campaign Featuring Colorescience 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 4
... successfully modified a common plant virus to deliver drugs ... affecting surrounding tissue. These tiny "smart bombs" - each ... a human hair - could lead to more effective ... effects. , Drs. Stefan Franzen, professor of chemistry, and ...
... Worldwide, Inc., an accredited provider of continuing medical education ... an online repository of resources and education on the ... health care practitioners.The goal of Managing Myeloma ... provide an extensive array of programs to support clinical ...
... first of its kind Global,Consumer Study is here! ... that,compares consumer trends in 15 countries. ISPA, working ... France,Germany, India, Italy, Japan, Russia, Singapore, Spain, Thailand, UK ... information on why people,spa in the 2008 Global Consumer ...
... body quickly needs to restore the vital blood volume. This ... the bone marrow. These hematopoietic stem cells remain dormant throughout ... of injury and loss of blood. Then they immediately start ... This has recently been shown by a group of scientists ...
... 12 Cardium Therapeutics (NYSE Alternext US: CXM) ... that InnerCool,s CoolBlue surface temperature modulation system was ... Chicago,s NBC 5 News. The story can ... segment features a maternity patient who suffered cardiac ...
... article published in the February 11 issue of the ... physicians to better understand what constitutes quality hospice and ... be best for their patients. Options for care at ... With more than 1,400 hospital-based palliative care programs ...
Cached Medicine News:Health News:Nanoparticle 'smart bomb' targets drug delivery to cancer cells 2Health News:Managing Myeloma (www.managingmyeloma.com) Launches - A Comprehensive Information and Educational Site for Physicians, Nurse Practitioners, Physician Assistants, and Pharmacists 2Health News:Worldwide, Stress is the No.1 Reason People Spa 2Health News:Stem cells: Deathly awakening by interferon 2Health News:TV News Coverage Reports on InnerCool's CoolBlue System Treatment of Cardiac Shock Patient Following Childbirth at Rush Hospital, Chicago 2Health News:TV News Coverage Reports on InnerCool's CoolBlue System Treatment of Cardiac Shock Patient Following Childbirth at Rush Hospital, Chicago 3Health News:TV News Coverage Reports on InnerCool's CoolBlue System Treatment of Cardiac Shock Patient Following Childbirth at Rush Hospital, Chicago 4Health News:TV News Coverage Reports on InnerCool's CoolBlue System Treatment of Cardiac Shock Patient Following Childbirth at Rush Hospital, Chicago 5Health News:TV News Coverage Reports on InnerCool's CoolBlue System Treatment of Cardiac Shock Patient Following Childbirth at Rush Hospital, Chicago 6Health News:TV News Coverage Reports on InnerCool's CoolBlue System Treatment of Cardiac Shock Patient Following Childbirth at Rush Hospital, Chicago 7Health News:JAMA Article Provides Guidance to Physicians on End-of-Life Care 2
Inquire...
... Liquichek Specialty Immunoassay Control ... assayed control designed to ... and Liquichek Immunoassay Plus ... specially formulated to include ...
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
Medicine Products: